Bioequivalence studies for GCC submission [Design Issues]

posted by professionalr – India, 2025-01-31 00:00 (140 d 02:51 ago) – Posting: # 24353
Views: 2,015

Hi friends,
Would it be acceptable to conduct bioequivalence studies for GCC submission at CRO if the facility has already been inspected by the US FDA? We don’t have separate GCC facility approval.

Thanks,
RP.

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,677 registered users;
37 visitors (0 registered, 37 guests [including 10 identified bots]).
Forum time: 03:51 CEST (Europe/Vienna)

Complex, statistically improbable things are by their nature
more difficult to explain than
simple, statistically probable things.    Richard Dawkins

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5